50 Ken Fisher Abbott Laboratories Trades
Ken Fisher's position in Abbott Laboratories is currently worth $1.58B. That's 0.58% of their equity portfolio (49th largest holding). The first Abbott Laboratories trade was made in Q1 2013. Since then Ken Fisher bought shares 36 more times and sold shares on thirteen occasions. The stake costed the investor $1.15B, netting the investor a gain of 37% so far.
News about Abbott Laboratories and Ken Fisher
Global Tissue Diagnostics Market to Reach $5.1 Billion by 2025
SAN FRANCISCO , March 28, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, toda...
Cardiac Biomarkers Market Top Key Players , SWOT Analysis, Growth and Forecast Till 2030 | BioMerieux, Abbott Laboratories, Siemens Healthcare, Thermo Fisher Scientific
Cardiac Biomarkers Market: Overview The solution from the cardiac biomarkers market prevents cardiac disease by effective monitoring of heart conditions. For...
Autoimmune Disease Diagnostics Market to Witness Huge Growth by 2028 | Thermo Fisher Scientific, Siemens Healthineers, Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, Inc
The global Autoimmune Disease Diagnostics Market size is expected to grow from USD 6.3 billion by 2028 from USD 4.1 billion in 2021, at a CAGR of +8%. A rese...
Infectious Illness POC Diagnostics Market Measurement | Is Anticipated to Attain USD 3.96 Billion by 2028 whereas Exhibiting an Spectacular CAGR of 17.2%
Key Distinguished Gamers Lined within the Infectious Illness Level of Care Diagnostics Market Analysis Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerlan...